Abstract
The cover image representing article number 1900161 by Jonathan F Lovell and co-workers shows aggregates formed by the anti-cancer drug cabazitaxel. In this work, it is shown that by co-formulating cabazitaxel in unique surfactant micelles with certain other hydrophobic cargo, aggregation can be prevented, resulting in a potent chemotherapy formulation with long-term liquid storage stability and a high drug-to-excipient ratio.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
